Nolipax

Nolipax Brand names, Nolipax Analogs

Nolipax Brand Names Mixture

No information avaliable

Nolipax Chemical_Formula

C₂₀H₂₁ClO₄

Nolipax RX_link

http://www.rxlist.com/cgi/generic3/fenofibrate.htm

Nolipax fda sheet

Nolipax FDA

Nolipax msds (material safety sheet)

Nolipax MSDS

Nolipax Synthesis Reference

No information avaliable

Nolipax Molecular Weight

360.831 g/mol

Nolipax Melting Point

80.5 °C

Nolipax H₂O Solubility

0.25mg/ml at 25 °C

Nolipax State

Solid

Nolipax LogP

5.575

Nolipax Dosage Forms

Capsule; Tablet

Nolipax Indication

For use as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb)

Nolipax Pharmacology

Fenofibrate is a lipid regulating agent indicated as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb). Fenofibrate is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (Fredrickson Types IV and V hyperlipidemia). Fenofibric acid, the active metabolite of Fenofibrate, produces reductions in total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) in treated patients. In addition, treatment with fenofibrate results in increases in high density lipoprotein (HDL) and apoproteins apoAI and apoAII.

Nolipax Absorption

Fenofibrate is well absorbed from the gastrointestinal tract. After absorption, fenofibrate is mainly excreted in the urine in the form of metabolites, primarily fenofibric acid and fenofibric acid glucuronide

Nolipax side effects and Toxicity

LD₅₀=1600 mg/kg (Oral, in mice); Investigated as a teratogen and reproductive hazard.

Nolipax Patient Information